Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity
Shabirul Haque, Sarah R. Vaiselbuh
Cancers (2021) Vol. 13, Iss. 6, pp. 1401-1401
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
Manasi P. Jogalekar, Ramya Lakshmi Rajendran, Fatima Khan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 138
New advances in exosome-based targeted drug delivery systems
Débora Ferreira, João Nuno Moreira, L. R. Rodrigues
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103628-103628
Open Access | Times Cited: 105
Sequential Targeting Hybrid Nanovesicles Composed of Chimeric Antigen Receptor T-Cell-Derived Exosomes and Liposomes for Enhanced Cancer Immunochemotherapy
Tianchuan Zhu, Zhenxing Chen, Guanmin Jiang, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16770-16786
Closed Access | Times Cited: 55
Targeting Senescent Alveolar Epithelial Cells Using Engineered Mesenchymal Stem Cell-Derived Extracellular Vesicles To Treat Pulmonary Fibrosis
Yaoying Long, B. S. Yang, Qian Lei, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 7046-7063
Closed Access | Times Cited: 18
Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies
Amirata Mohseni, Fatemeh Salehi, Samaneh Rostami, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy
Wu Manling, Min Wang, Haoyuan Jia, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2513-2538
Open Access | Times Cited: 53
Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: Current status and future perspectives
Mohammad Azam Ansari, Muthu Thiruvengadam, Baskar Venkidasamy, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 678-696
Closed Access | Times Cited: 44
The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy
Kewen Qian, Wenyan Fu, Tian Li, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 44
The role of MSCs and CAR-MSCs in cellular immunotherapy
Lun Yan, Jing Li, Cheng Zhang
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Therapeutic antibodies for the prevention and treatment of cancer
Mukesh Kumar, Akansha Jalota, Ashutosh Kumar, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 16
CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Exosome-based nanoparticles and cancer immunotherapy
Jiarong Ye, Danni Li, Yiting Jie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117296-117296
Open Access | Times Cited: 13
Emerging Strategies to Overcome Current CAR-T Therapy Dilemmas - Exosomes Derived from CAR-T Cells
Dong Hu, Ruyue Yang, Guidan Wang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2773-2791
Open Access | Times Cited: 12
CAR-T cell therapy: a game-changer in cancer treatment and beyond
Kumar Utkarsh, Namita Srivastava, Sachin Kumar, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 6, pp. 1300-1318
Closed Access | Times Cited: 11
Biomedical application of small extracellular vesicles in cancer treatment
Salomé Araujo‐Abad, Miguel Saceda, Camino de Juan Romero
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114117-114117
Closed Access | Times Cited: 35
T Lymphocyte and CAR-T Cell-Derived Extracellular Vesicles and Their Applications in Cancer Therapy
Víctor Calvo, Manuel Izquierdo
Cells (2022) Vol. 11, Iss. 5, pp. 790-790
Open Access | Times Cited: 32
Lyophilization Based Isolation of Exosomes
Rida e Maria Qazi, Zahra Sajid, Chunqiu Zhao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10477-10477
Open Access | Times Cited: 19
Engineered exosomes in emerging cell-free therapy
Chaohua Si, Jianen Gao, Xu Ma
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Advances in nano-immunotherapy for hematological malignancies
Jian Xu, Wenqi Liu, Fengjuan Fan, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
CAR-T cell-derived exosomes: a new perspective for cancer therapy
Farnaz Sani, Shabnam Shojaei, Seyed Amirhossein Tabatabaei, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Mechanisms and strategies for safe chimeric antigen receptor T‐cell activity control
Sophia Stock, Anna‐Kristina Klüver, Luisa Fertig, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 10, pp. 1706-1725
Open Access | Times Cited: 14
CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy
Jiawen Huang, Qian Yang, Wen Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Application of cell-derived exosomes in the hematological malignancies therapy
Kazem Ghaffari, Amin Moradi-Hasanabad, Ali Sobhani‐Nasab, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment
David Van Morckhoven, Nathan Dubois, Dominique Bron, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
“Innovations in Cancer Immunotherapy: A Comprehensive Overview of Recent Breakthroughs and Future Directions"
Chou‐Yi Hsu, Harikumar Pallathadka, Saade Abdalkareem Jasim, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104588-104588
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top